Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS).
Articolo
Data di Pubblicazione:
2008
Citazione:
Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS) / Revicki, Dennis A; Luo, Michelle P; Wordsworth, Paul; Wong, Robert L; Chen, Naijun; Davis, John C; Atlas, ; Salvarani, Carlo. - In: THE JOURNAL OF RHEUMATOLOGY. - ISSN 0315-162X. - 35:7(2008), pp. 1346-1353.
Abstract:
To evaluate the effect of adalimumab on pain, fatigue, and stiffness in patients with active ankylosing spondylitis (AS).
Tipologia CRIS:
Articolo su rivista
Keywords:
Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Female; Humans; Male; Middle Aged; Quality of Life; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha
Elenco autori:
Revicki, Dennis A; Luo, Michelle P; Wordsworth, Paul; Wong, Robert L; Chen, Naijun; Davis, John C; Atlas, ; Salvarani, Carlo
Link alla scheda completa:
Pubblicato in: